Ultralife (NASDAQ:ULBI – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, November 8th. Parties interested in listening to the company’s conference call can do so using this link.
Ultralife Trading Down 5.2 %
Shares of NASDAQ:ULBI opened at $8.41 on Friday. The stock has a market capitalization of $139.80 million, a price-to-earnings ratio of 14.15 and a beta of 0.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.06 and a current ratio of 4.07. The stock’s 50-day simple moving average is $9.44 and its two-hundred day simple moving average is $10.35. Ultralife has a 52-week low of $6.36 and a 52-week high of $13.39.
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut Ultralife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 3rd.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading
- Five stocks we like better than Ultralife
- What is the Nasdaq? Complete Overview with History
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What is a Death Cross in Stocks?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Breakout Stocks: What They Are and How to Identify Them
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.